Miftek Corporation logo — Single photon array technology transforming light detection

Miftek Corporation

Single photon array technology transforming light detection

Founded 2013 United States West Lafayette, United States 18 employees Grant Total: $250.00K Biotechnology, Health Care

General Information

Company Name Miftek Corporation
Founded Year 2013
Location United States West Lafayette, United States
Employees 18
Industries Biotechnology, Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Miftek Corporation. To contact Miftek Corporation, visit miftek.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Miftek Corporation

MIFtek Inc., founded in 2013 and headquartered in the United States, is a pioneering biotechnology company with a slogan, "Single photon array technology transforming light detection." The company is dedicated to next-generation cellular analysis solutions within the micro-fluidic domain to identify cellular systems and their function. MIFtek's goal is to develop next-generation diagnostic tools. The company has made significant strides in photon detection technology and has successfully integrated it into new devices. Notably, the team at MIFtek holds the distinction of being the first to develop and patent Spectral Flow Cytometry. MIFtek recently secured a $250.00K grant investment on 07 May 2020 from the National Science Foundation. This investment serves as a testament to the potential and innovation of the company's technology and validates their commitment to revolutionizing cellular analysis. With a strong focus on advancing cellular analysis, MIFtek is positioned as a key player in the biotechnology and healthcare industries, and is poised to make significant contributions to the future of diagnostic tools.

Taxonomy: Indiana, technology development, cellular analysis, micro-fluidic, diagnostic tools, photon detection, Spectral Flow Cytometry, innovation, patent, biomedical engineering

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $250.00K 1
National Science Foundation
07 May 2020

Miftek Corporation Alternatives & Competitors

Miftek Corporation vs
Dyameo
Dyameo France

Dyameo est une société de recherche & développement dans le domaine des dispositifs médicaux qui con...

Seed
8 employees
Biotechnology, Health Care
Miftek Corporation vs
Sanome
Sanome United Kingdom

Closing the gap between data and decision in healthcare - making hospitals safer, smarter and more e...

Pre-Seed
30 employees
Biotechnology, Health Care
Miftek Corporation vs

VDO QuantoBio is a World Leading Flow Cytometry Solution Manufacturer in flow cytometer and FC reage...

Post-IPO Equity
9 employees
Biotechnology, Health Care

FAQ About Miftek Corporation

Single photon array technology transforming light detection
Miftek Corporation was founded in 2013.
Miftek Corporation is headquartered in West Lafayette, United States.
Miftek Corporation operates in Biotechnology and Health Care. Its work centres on Indiana, technology development, cellular analysis and micro-fluidic.
Miftek Corporation has approximately 18 employees.
Miftek Corporation has completed 1 funding round, raising a total of $250.00K. The latest funding stage is Grant.
Top alternatives and competitors to Miftek Corporation include Dyameo, Sanome, VDO QuantoBio, Fast Biomedical, Polaris Biology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Miftek Corporation and Dyameo are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Miftek Corporation, https://bouncewatch.com/company/miftek, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes